CRO in Clinical Trials Market Report – Research, Industry Analysis Reports and Market Demands

Global CRO in Clinical Trials Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of CRO in Clinical Trials by Type
- 1.3.1 Overview: Global CRO in Clinical Trials Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global CRO in Clinical Trials Consumption Value Market Share by Type in 2023
- 1.3.3 Phase I Trial
- 1.3.4 Phase II Trial
- 1.3.5 Phase III Trial
- 1.3.6 Phase IV Trial
1.4 Global CRO in Clinical Trials Market by Application
- 1.4.1 Overview: Global CRO in Clinical Trials Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Pharmaceutical
- 1.4.3 Bio-pharm
- 1.4.4 Others
1.5 Global CRO in Clinical Trials Market Size & Forecast
1.6 Global CRO in Clinical Trials Market Size and Forecast by Region
- 1.6.1 Global CRO in Clinical Trials Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global CRO in Clinical Trials Market Size by Region, (2019-2030)
- 1.6.3 North America CRO in Clinical Trials Market Size and Prospect (2019-2030)
- 1.6.4 Europe CRO in Clinical Trials Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific CRO in Clinical Trials Market Size and Prospect (2019-2030)
- 1.6.6 South America CRO in Clinical Trials Market Size and Prospect (2019-2030)
- 1.6.7 Middle East & Africa CRO in Clinical Trials Market Size and Prospect (2019-2030)

2 Company Profiles

3 Market Competition, by Players

3.1 Global CRO in Clinical Trials Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of CRO in Clinical Trials by Company Revenue
- 3.2.2 Top 3 CRO in Clinical Trials Players Market Share in 2023
- 3.2.3 Top 6 CRO in Clinical Trials Players Market Share in 2023
3.3 CRO in Clinical Trials Market: Overall Company Footprint Analysis
- 3.3.1 CRO in Clinical Trials Market: Region Footprint
- 3.3.2 CRO in Clinical Trials Market: Company Product Type Footprint
- 3.3.3 CRO in Clinical Trials Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global CRO in Clinical Trials Consumption Value and Market Share by Type (2019-2024)
4.2 Global CRO in Clinical Trials Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

5.1 Global CRO in Clinical Trials Consumption Value Market Share by Application (2019-2024)
5.2 Global CRO in Clinical Trials Market Forecast by Application (2025-2030)

6 North America

6.1 North America CRO in Clinical Trials Consumption Value by Type (2019-2030)
6.2 North America CRO in Clinical Trials Market Size by Application (2019-2030)
6.3 North America CRO in Clinical Trials Market Size by Country
- 6.3.1 North America CRO in Clinical Trials Consumption Value by Country (2019-2030)
- 6.3.2 United States CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 6.3.3 Canada CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 6.3.4 Mexico CRO in Clinical Trials Market Size and Forecast (2019-2030)

7 Europe

7.1 Europe CRO in Clinical Trials Consumption Value by Type (2019-2030)
7.2 Europe CRO in Clinical Trials Consumption Value by Application (2019-2030)
7.3 Europe CRO in Clinical Trials Market Size by Country
- 7.3.1 Europe CRO in Clinical Trials Consumption Value by Country (2019-2030)
- 7.3.2 Germany CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 7.3.3 France CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 7.3.5 Russia CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 7.3.6 Italy CRO in Clinical Trials Market Size and Forecast (2019-2030)

8 Asia-Pacific

8.1 Asia-Pacific CRO in Clinical Trials Consumption Value by Type (2019-2030)
8.2 Asia-Pacific CRO in Clinical Trials Consumption Value by Application (2019-2030)
8.3 Asia-Pacific CRO in Clinical Trials Market Size by Region
- 8.3.1 Asia-Pacific CRO in Clinical Trials Consumption Value by Region (2019-2030)
- 8.3.2 China CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 8.3.3 Japan CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 8.3.4 South Korea CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 8.3.5 India CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 8.3.7 Australia CRO in Clinical Trials Market Size and Forecast (2019-2030)

9 South America

9.1 South America CRO in Clinical Trials Consumption Value by Type (2019-2030)
9.2 South America CRO in Clinical Trials Consumption Value by Application (2019-2030)
9.3 South America CRO in Clinical Trials Market Size by Country
- 9.3.1 South America CRO in Clinical Trials Consumption Value by Country (2019-2030)
- 9.3.2 Brazil CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 9.3.3 Argentina CRO in Clinical Trials Market Size and Forecast (2019-2030)

10 Middle East & Africa

10.1 Middle East & Africa CRO in Clinical Trials Consumption Value by Type (2019-2030)
10.2 Middle East & Africa CRO in Clinical Trials Consumption Value by Application (2019-2030)
10.3 Middle East & Africa CRO in Clinical Trials Market Size by Country
- 10.3.1 Middle East & Africa CRO in Clinical Trials Consumption Value by Country (2019-2030)
- 10.3.2 Turkey CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia CRO in Clinical Trials Market Size and Forecast (2019-2030)
- 10.3.4 UAE CRO in Clinical Trials Market Size and Forecast (2019-2030)

11 Market Dynamics

11.1 CRO in Clinical Trials Market Drivers
11.2 CRO in Clinical Trials Market Restraints
11.3 CRO in Clinical Trials Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 CRO in Clinical Trials Industry Chain
12.2 CRO in Clinical Trials Upstream Analysis
12.3 CRO in Clinical Trials Midstream Analysis
12.4 CRO in Clinical Trials Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries.
Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others.
In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor’s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).
According to our (Global Info Research) latest study, the global CRO in Clinical Trials market size was valued at US$ 48580 million in 2023 and is forecast to a readjusted size of USD 89680 million by 2030 with a CAGR of 9.3% during review period.
Global core CRO in clinical trials players include Labcorp, IQVIA and Parexel etc. The top 5 companies hold a share about 40%. North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 35% and 20%.
In terms of product, phase iii trial is the largest segment, with a share about 35%. And in terms ofend users, the largest end user is pharmaceutical，with a share about 55%.
This report is a detailed and comprehensive analysis for global CRO in Clinical Trials market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global CRO in Clinical Trials market size and forecasts, in consumption value ($ Million), 2019-2030
Global CRO in Clinical Trials market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global CRO in Clinical Trials market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global CRO in Clinical Trials market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CRO in Clinical Trials
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CRO in Clinical Trials market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, MedPace, Wuxi AppTec, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
CRO in Clinical Trials market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
CRO in Clinical Trials market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Phase I Trial
Phase II Trial
Phase III Trial
Phase IV Trial
Market segment by Application
Pharmaceutical
Bio-pharm
Others
Market segment by players, this report covers
Labcorp
IQVIA
Parexel
Syneos Health
PRA Health Sciences
PPD
ICON
MedPace
Wuxi AppTec
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CRO in Clinical Trials product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRO in Clinical Trials, with revenue, gross margin, and global market share of CRO in Clinical Trials from 2019 to 2024.
Chapter 3, the CRO in Clinical Trials competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CRO in Clinical Trials market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CRO in Clinical Trials.
Chapter 13, to describe CRO in Clinical Trials research findings and conclusion.

Buy now